VRT vs. RYTM
VRT (Vertiv Holdings Co.) and RYTM (Rhythm Pharmaceuticals, Inc.) are both stocks. VRT operates in Electrical Equipment & Parts (Industrials), while RYTM operates in Biotechnology (Healthcare). Over the past 5 years, VRT returned 62.98%/yr vs 35.24%/yr for RYTM. At a 0.20 correlation, their price movements are largely independent.
Performance
VRT vs. RYTM - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, VRT achieves a 85.57% return, which is significantly higher than RYTM's -19.73% return.
VRT
- 1D
- 0.02%
- 1M
- -11.59%
- YTD
- 85.57%
- 6M
- 61.97%
- 1Y
- 160.87%
- 3Y*
- 142.34%
- 5Y*
- 62.98%
- 10Y*
- —
RYTM
- 1D
- -0.55%
- 1M
- -8.76%
- YTD
- -19.73%
- 6M
- -18.31%
- 1Y
- 26.16%
- 3Y*
- 70.19%
- 5Y*
- 35.24%
- 10Y*
- —
VRT vs. RYTM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
VRT Vertiv Holdings Co. | 85.57% | 42.80% | 136.82% | 251.81% | -45.25% | 33.80% | 69.36% | 12.55% | 1.03% |
RYTM Rhythm Pharmaceuticals, Inc. | -19.73% | 91.21% | 21.78% | 57.86% | 191.78% | -66.43% | 29.49% | -14.58% | -11.29% |
Correlation
The correlation between VRT and RYTM is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.13 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.20 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.22 |
Correlation (All Time) Calculated using the full available price history since Jul 30, 2018 | 0.20 |
Fundamentals
VRT:
$117.86B
RYTM:
$5.84B
VRT:
$3.99
RYTM:
-$3.10
VRT:
10.84
RYTM:
26.00
VRT:
27.77
RYTM:
712.63
VRT:
$10.84B
RYTM:
$217.17M
VRT:
$3.92B
RYTM:
$194.16M
VRT:
$2.35B
RYTM:
-$182.86M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
VRT vs. RYTM — Risk / Return Rank
VRT
RYTM
VRT vs. RYTM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Vertiv Holdings Co. (VRT) and Rhythm Pharmaceuticals, Inc. (RYTM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| VRT | RYTM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.33 | ||
| Sortino ratioReturn per unit of downside risk | +2.02 | ||
| Omega ratioGain probability vs. loss probability | 1.41 | 1.15 | +0.26 |
| Calmar ratioReturn relative to maximum drawdown | 6.53 | 0.74 | +5.79 |
| Martin ratioReturn relative to average drawdown | 18.20 | 1.74 | +16.46 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| VRT | RYTM | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.79 | 0.46 | +2.33 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 1.03 | 0.46 | +0.56 |
Sharpe Ratio (All Time)Calculated using the full available price history | 1.00 | 0.18 | +0.82 |
Drawdowns
VRT vs. RYTM - Drawdown Comparison
The maximum VRT drawdown since its inception was -71.24%, smaller than the maximum RYTM drawdown of -92.10%. Use the drawdown chart below to compare losses from any high point for VRT and RYTM.
Loading charts...
Drawdown Indicators
| VRT | RYTM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -71.24% | -92.10% | +20.86% |
Max Drawdown (1Y)Largest decline over 1 year | -24.78% | -35.54% | +10.76% |
Max Drawdown (3Y)Largest decline over 3 years | -61.28% | -35.54% | -25.74% |
Max Drawdown (5Y)Largest decline over 5 years | -71.24% | -85.49% | +14.25% |
Current DrawdownCurrent decline from peak | -20.11% | -26.95% | +6.84% |
Average DrawdownAverage peak-to-trough decline | -16.22% | -32.18% | +15.96% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.89% | 15.08% | -6.19% |
Volatility
VRT vs. RYTM - Volatility Comparison
Vertiv Holdings Co. (VRT) has a higher volatility of 16.60% compared to Rhythm Pharmaceuticals, Inc. (RYTM) at 14.47%. This indicates that VRT's price experiences larger fluctuations and is considered to be riskier than RYTM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| VRT | RYTM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.60% | 14.47% | +2.13% |
Volatility (6M)Calculated over the trailing 6-month period | 45.55% | 36.66% | +8.89% |
Volatility (1Y)Calculated over the trailing 1-year period | 58.11% | 57.36% | +0.75% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 61.81% | 76.40% | -14.59% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 54.61% | 70.96% | -16.35% |
Dividends
VRT vs. RYTM - Dividend Comparison
VRT's dividend yield for the trailing twelve months is around 0.07%, while RYTM has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
RYTM Rhythm Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
VRT Vertiv Holdings Co. | 0.07% | 0.11% | 0.10% | 0.05% | 0.07% | 0.04% | 0.05% |
Financials
VRT vs. RYTM - Financials Comparison
This section allows you to compare key financial metrics between Vertiv Holdings Co. and Rhythm Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
VRT vs. RYTM - Profitability Comparison
VRT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Vertiv Holdings Co. reported a gross profit of 999.70M and revenue of 2.65B. Therefore, the gross margin over that period was 37.7%.
RYTM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Rhythm Pharmaceuticals, Inc. reported a gross profit of 52.96M and revenue of 60.11M. Therefore, the gross margin over that period was 88.1%.
VRT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Vertiv Holdings Co. reported an operating income of 440.10M and revenue of 2.65B, resulting in an operating margin of 16.6%.
RYTM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Rhythm Pharmaceuticals, Inc. reported an operating income of -52.36M and revenue of 60.11M, resulting in an operating margin of -87.1%.
VRT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Vertiv Holdings Co. reported a net income of 390.10M and revenue of 2.65B, resulting in a net margin of 14.7%.
RYTM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Rhythm Pharmaceuticals, Inc. reported a net income of -56.74M and revenue of 60.11M, resulting in a net margin of -94.4%.
Frequently Asked Questions
VRT and RYTM have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
VRT has higher volatility (16.60%) compared to RYTM (14.47%). In terms of maximum drawdown, VRT dropped -71.24% vs RYTM's -92.10%.
VRT currently has the higher Sharpe Ratio (2.79 vs 0.46), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for VRT and RYTM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer